MyFinsight
Home
About
Contact
Back
Income Statement
Zentalis Pharmaceuticals, Inc. (ZNTL)
source: myfinsight.com
Download
Download image
Net loss
attributable to zentalis
-$26,874K
(69.56%↑ Y/Y)
Net loss
-$26,874K
(69.56%↑ Y/Y)
Net loss before
income taxes
-$26,874K
Investment and other income
(expense), net
$9,184K
(140.17%↑ Y/Y)
Loss from operations
-$36,058K
(44.65%↑ Y/Y)
Total operating
expenses
$36,058K
(-44.65%↓ Y/Y)
General and
administrative
$8,448K
(-49.60%↓ Y/Y)
Research and development
$27,610K
(-42.94%↓ Y/Y)
Back